These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3056415)

  • 1. Protein kinase C and dopamine release--II. Effect of dopamine acting drugs in vivo.
    Giambalvo CT
    Biochem Pharmacol; 1988 Oct; 37(20):4009-17. PubMed ID: 3056415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C and dopamine release--III. Effect of dopamine depleting drugs.
    Giambalvo CT
    Biochem Pharmacol; 1989 Dec; 38(24):4445-54. PubMed ID: 2574975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT; Wagner RL
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
    Boyar WC; Altar CA
    J Neurochem; 1987 Mar; 48(3):824-31. PubMed ID: 2949060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
    Suaud-Chagny MF; Ponec J; Gonon F
    Neuroscience; 1991; 45(3):641-52. PubMed ID: 1775239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.
    Winkler JD; Thermos K; Weiss B
    Psychopharmacology (Berl); 1987; 92(3):285-91. PubMed ID: 2957717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE; Howard SG
    Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.